investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

NPC Clinical Follow-up Study (BtoB Study)

Allan Hildesheim

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Study of Epstein-Barr virus (EBV) biomarkers in predicting nasopharyngeal carcinoma (NPC) risk in high-risk individuals from multiplex families, defined as families with 2 or more NPC cases. Results from our study will impact clinical management in individuals with high-risk of NPC.

Related projects

Allan Hildesheim

Nasopharyngeal carcinoma in Taiwan

Nasopharynx

Pathology

Allan Hildesheim

Case-control Study of Nasopharyngeal Carcinoma in North Africa

Nasopharynx

Pathology

Allan Hildesheim

Case-Control Studies of NPC in Taiwan

Nasopharynx

Pathology

Allan Hildesheim

NPC Clinical Follow-up Studies in Asia

Nasopharynx

Pathology

Allan Hildesheim

Family Studies of Nasopharyngeal Carcinoma

Nasopharynx

Pathology

Allan Hildesheim

NPC family study in Taiwan

Nasopharynx

Pathology

Allan Hildesheim

NPC Multicentric Study

Nasopharynx

Pathology

Margaret Juliana Mcelrath

Seattle-Lausanne-Kampala CTU

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

Gary Gilliland

Cancer Center Support Grant (comprehensive)

Trachea, bronchus and lung Prostate Pancreas Ovary Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Melanoma of skin Non-Melanoma skin cancer Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Colorectum Cervix uteri Breast Brain, nervous system